Litcius/Paper detail

Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients

Daniel Whittam, Álvaro Cobo‐Calvo, A. Sebastian López‐Chiriboga, Santiago Pardo, Matthew Gornall, Silvia Cicconi, Alexander U. Brandt, Klaus Berek, Thomas Berger, Ilijas Jelčić, Grace Gombolay, Luana Micheli Oliveira, Dagoberto Callegaro, Kimihiko Kaneko, Tatsuro Misu, Marco Capobianco, Emily Gibbons, Venkatraman Karthikeayan, Bruno Brochet, Bertrand Audoin, Guillaume Mathey, David Laplaud, Éric Thouvenot, Mikaël Cohen, Ayman Tourbah, Élisabeth Maillart, Jonathan Ciron, Romain Deschamps, Damien Biotti, Kevin Rostásy, Rinze F. Neuteboom, Cheryl Hemingway, Rob Forsyth, Marcelo Matiello, Stewart Webb, David Hunt, Katy Murray, Yael Hacohen, Ming Lim, Maria Isabel Leite, Jacqueline Palace, Tom Solomon, Andreas Lutterotti, Kazuo Fujihara, Ichiro Nakashima, Jeffrey L. Bennett, Lekha Pandit, Tanuja Chitnis, Brian G. Weinshenker, Brigitte Wildemann, Douglas Kazutoshi Sato, Su‐Hyun Kim, Saif Huda, Ho Jin Kim, Markus Reindl, Michael Levy, Sven Jarius, Sílvia Tenembaum, Friedemann Paul, Sean J. Pittock, Romain Marignier, Anu Jacob

2020Multiple Sclerosis and Related Disorders179 citationsDOIOpen Access PDF

Topics & Concepts

MedicineRituximabInternal medicineGastroenterologyPopulationFingolimodMultiple sclerosisAlemtuzumabSurgeryImmunologyLymphomaTransplantationEnvironmental healthMultiple Sclerosis Research StudiesAutoimmune Neurological Disorders and TreatmentsMultiple Myeloma Research and Treatments
Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients | Litcius